Idun deal

The La Jolla, Calif., company reached a licensing agreement with ARCH Development Corp. (the licensing arm of the University of Chicago) and the University of Michigan, for the rights to the human programmed cell death gene, bcl-x.

IDUN said the gene, a homologue of the human proto-oncogene bcl-2, has promise in cancer and inflammation. ...